Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Immunogenicity and Safety Study of Kinrix® Co-administered With Varivax®
Brief Summary: The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® \[varicella virus vaccine live\], Merck and Company) and (measles mumps rubella) MMR vaccines, compared to Kinrix co-administered with MMR vaccine alone. Both Kinrix and the second dose of Varivax are indicated in children 4-6 years of age, and there is great potential for the vaccines to be given concurrently. The aim of this trial is to demonstrate that co-administered Varivax does not negatively affect the immunogenicity or reactogenicity of Kinrix.


Options:
A: Arm Label: BOOSTRIX POLIO GROUP; Type: EXPERIMENTAL; Interventions: Biological: Boostrix Polio™ 711866, Biological: Priorix Tetra TM 208136 | Arm Label: TETRAVAC GROUP; Type: ACTIVE_COMPARATOR; Interventions: Biological: Priorix Tetra TM 208136, Biological: Tetravac TM | Intervention Type: BIOLOGICAL; Name: Boostrix Polio™ 711866; Assigned to Arm(s): BOOSTRIX POLIO GROUP | Intervention Type: BIOLOGICAL; Name: Priorix Tetra TM 208136; Assigned to Arm(s): BOOSTRIX POLIO GROUP, TETRAVAC GROUP | Intervention Type: BIOLOGICAL; Name: Tetravac TM; Assigned to Arm(s): TETRAVAC GROUP
B: Arm Label: Kinrix + M-M-R II + Varivax; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals'Kinrix®, Biological: Merck and Company's MMRII, Biological: Merck and Company's Varivax | Arm Label: Kinrix + M-M-R II -> Varivax; Type: ACTIVE_COMPARATOR; Interventions: Biological: GSK Biologicals'Kinrix®, Biological: Merck and Company's MMRII, Biological: Merck and Company's Varivax | Intervention Type: BIOLOGICAL; Name: GSK Biologicals'Kinrix®; Assigned to Arm(s): Kinrix + M-M-R II + Varivax, Kinrix + M-M-R II -> Varivax | Intervention Type: BIOLOGICAL; Name: Merck and Company's MMRII; Assigned to Arm(s): Kinrix + M-M-R II + Varivax, Kinrix + M-M-R II -> Varivax | Intervention Type: BIOLOGICAL; Name: Merck and Company's Varivax; Assigned to Arm(s): Kinrix + M-M-R II + Varivax, Kinrix + M-M-R II -> Varivax
C: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Biological: Priorix-Tetra™ (MMRV vaccine 208136), Biological: Havrix®, Biological: Prevnar® | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Biological: Priorix-Tetra™ (MMRV vaccine 208136), Biological: Havrix®, Biological: Prevnar® | Arm Label: Group C; Type: ACTIVE_COMPARATOR; Interventions: Biological: ProQuad®, Biological: Havrix®, Biological: Prevnar® | Intervention Type: BIOLOGICAL; Name: Priorix-Tetra™ (MMRV vaccine 208136); Assigned to Arm(s): Group A, Group B | Intervention Type: BIOLOGICAL; Name: ProQuad®; Assigned to Arm(s): Group C | Intervention Type: BIOLOGICAL; Name: Havrix®; Assigned to Arm(s): Group A, Group B, Group C | Intervention Type: BIOLOGICAL; Name: Prevnar®; Assigned to Arm(s): Group A, Group B, Group C
D: Arm Label: Menhibrix A Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: Menhibrix B Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: Menhibrix C Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: Menhibrix Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, Biological: Pediarix, Biological: Prevnar, Biological: M-M-R II, Biological: Varivax | Arm Label: ActHIB Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: ActHIB, Biological: PedvaxHIB | Intervention Type: BIOLOGICAL; Name: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: ActHIB; Assigned to Arm(s): ActHIB Group | Intervention Type: BIOLOGICAL; Name: PedvaxHIB; Assigned to Arm(s): ActHIB Group | Intervention Type: BIOLOGICAL; Name: Pediarix; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: Prevnar; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: M-M-R II; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group | Intervention Type: BIOLOGICAL; Name: Varivax; Assigned to Arm(s): Menhibrix A Group, Menhibrix B Group, Menhibrix C Group, Menhibrix Group

Answer: B